Cargando…
HIV-1 sequences in lentiviral vector genomes can be substantially reduced without compromising transduction efficiency
Many lentiviral vectors used for gene therapy are derived from HIV-1. An optimal vector genome would include only the viral sequences required for transduction efficiency and gene expression to minimize the amount of foreign sequence inserted into a patient’s genome. However, it remains unclear whet...
Autores principales: | Sertkaya, Helin, Ficarelli, Mattia, Sweeney, Nathan P., Parker, Hannah, Vink, Conrad A., Swanson, Chad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187449/ https://www.ncbi.nlm.nih.gov/pubmed/34103612 http://dx.doi.org/10.1038/s41598-021-91309-w |
Ejemplares similares
-
Minimal impact of ZAP on lentiviral vector production and transduction efficiency
por: Sertkaya, Helin, et al.
Publicado: (2021) -
The impact of lentiviral vector genome size and producer cell genomic to gag-pol mRNA ratios on packaging efficiency and titre
por: Sweeney, Nathan P., et al.
Publicado: (2021) -
CpG Dinucleotides Inhibit HIV-1 Replication through Zinc Finger Antiviral Protein (ZAP)-Dependent and -Independent Mechanisms
por: Ficarelli, Mattia, et al.
Publicado: (2020) -
Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors
por: Lei, Yuning, et al.
Publicado: (2009) -
Lentiviral vector transduction of spermatozoa as a tool for the study of early development
por: Chandrashekran, Anil, et al.
Publicado: (2014)